Global and Region Peripheral Intervention Drug-Eluting Devices Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Peripheral Intervention Drug-Eluting Devices market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Peripheral Intervention Drug-Eluting Devicesmarket, defines the market attractiveness level of Peripheral Intervention Drug-Eluting Devices market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Peripheral Intervention Drug-Eluting Devices industry, describes the types of Peripheral Intervention Drug-Eluting Devices market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peripheral Intervention Drug-Eluting Devices market and the development prospects and opportunities of Peripheral Intervention Drug-Eluting Devices industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peripheral Intervention Drug-Eluting Devices market in Chapter 13.

    By Player:

    • Medtronic plc

    • Abbott Laboratories

    • Cardinal Health

    • B Braun Melsungen AG

    • The Lubrizol Corporation

    • CR Bard, Inc

    • Biosensors International Group Ltd

    • Boston Scientific Corporation

    • Terumo Corporation

    • St Jude Medical, Inc

    By Type:

    • Plain Old Balloon Angioplasty (POBA)

    • Percutaneous Transluminal Angioplasty (PTA)

    By End-User:

    • Drug-Eluting Balloons

    • Drug-Eluting Stents

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Peripheral Intervention Drug-Eluting Devices Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Peripheral Intervention Drug-Eluting Devices Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Peripheral Intervention Drug-Eluting Devices Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Peripheral Intervention Drug-Eluting Devices Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Peripheral Intervention Drug-Eluting Devices Market Analysis and Outlook to 2022

    • 7.1 Global Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)

    • 7.2 United States Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)

    • 7.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)

    • 7.4 China Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)

    • 7.5 Japan Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)

    • 7.6 India Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)

    • 7.7 South Korea Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)

    8 Region and Country-wise Peripheral Intervention Drug-Eluting Devices Market Analysis and Outlook to 2028

    • 8.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)

    • 8.2 United States Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)

    • 8.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)

    • 8.4 China Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)

    • 8.5 Japan Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)

    • 8.6 India Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)

    • 8.7 South Korea Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)

    9 Global Peripheral Intervention Drug-Eluting Devices Market Outlook by Types and Applications to 2022

    • 9.1 Global Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Plain Old Balloon Angioplasty (POBA) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Percutaneous Transluminal Angioplasty (PTA) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drug-Eluting Balloons Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    10 Global Peripheral Intervention Drug-Eluting Devices Market Outlook by Types and Applications to 2028

    • 10.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Plain Old Balloon Angioplasty (POBA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Percutaneous Transluminal Angioplasty (PTA) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Drug-Eluting Balloons Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    11 Global Peripheral Intervention Drug-Eluting Devices Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Peripheral Intervention Drug-Eluting Devices Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Peripheral Intervention Drug-Eluting Devices Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Peripheral Intervention Drug-Eluting Devices Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Peripheral Intervention Drug-Eluting Devices Market Competitive Analysis

    • 14.1 Medtronic plc

      • 14.1.1 Medtronic plc Company Details

      • 14.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.2 Abbott Laboratories

      • 14.2.1 Abbott Laboratories Company Details

      • 14.2.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.3 Cardinal Health

      • 14.3.1 Cardinal Health Company Details

      • 14.3.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.4 B Braun Melsungen AG

      • 14.4.1 B Braun Melsungen AG Company Details

      • 14.4.2 B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.5 The Lubrizol Corporation

      • 14.5.1 The Lubrizol Corporation Company Details

      • 14.5.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.6 CR Bard, Inc

      • 14.6.1 CR Bard, Inc Company Details

      • 14.6.2 CR Bard, Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 CR Bard, Inc Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.7 Biosensors International Group Ltd

      • 14.7.1 Biosensors International Group Ltd Company Details

      • 14.7.2 Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.8 Boston Scientific Corporation

      • 14.8.1 Boston Scientific Corporation Company Details

      • 14.8.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.9 Terumo Corporation

      • 14.9.1 Terumo Corporation Company Details

      • 14.9.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Service

    • 14.10 St Jude Medical, Inc

      • 14.10.1 St Jude Medical, Inc Company Details

      • 14.10.2 St Jude Medical, Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 St Jude Medical, Inc Peripheral Intervention Drug-Eluting Devices Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Peripheral Intervention Drug-Eluting Devices

    • Figure Peripheral Intervention Drug-Eluting Devices Picture

    • Table Global Peripheral Intervention Drug-Eluting Devices Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)

    • Figure United States Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)

    • Table Europe Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)

    • Figure China Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)

    • Figure Japan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)

    • Figure India Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)

    • Figure South Korea Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)

    • Figure United States Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Plain Old Balloon Angioplasty (POBA) Consumption and Growth Rate (2017-2022)

    • Figure Global Percutaneous Transluminal Angioplasty (PTA) Consumption and Growth Rate (2017-2022)

    • Figure Global Drug-Eluting Balloons Consumption and Growth Rate (2017-2022)

    • Figure Global Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Global Plain Old Balloon Angioplasty (POBA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Percutaneous Transluminal Angioplasty (PTA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug-Eluting Balloons Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Export by Region (Top 5 Countries) (2017-2028)

    • Table Medtronic plc (Foundation Year, Company Profile and etc.)

    • Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table Cardinal Health (Foundation Year, Company Profile and etc.)

    • Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table B Braun Melsungen AG (Foundation Year, Company Profile and etc.)

    • Table B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table The Lubrizol Corporation (Foundation Year, Company Profile and etc.)

    • Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table CR Bard, Inc (Foundation Year, Company Profile and etc.)

    • Table CR Bard, Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table CR Bard, Inc Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table Biosensors International Group Ltd (Foundation Year, Company Profile and etc.)

    • Table Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)

    • Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table Terumo Corporation (Foundation Year, Company Profile and etc.)

    • Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Service

    • Table St Jude Medical, Inc (Foundation Year, Company Profile and etc.)

    • Table St Jude Medical, Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table St Jude Medical, Inc Peripheral Intervention Drug-Eluting Devices Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.